Skip to main content

Advertisement

Log in

Therapeutic strategy for acute pleural empyema: comparison between retrospective study and prospective study

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

The purpose of this study is to investigate the efficiency of therapeutic strategy for acute pleural empyema.

Methods

We retrospectively reviewed 121 acute empyema patients and evaluated the therapeutic strategy for acute pleural empyema. Then, we prospectively reviewed 114 acute pleural empyema patients based on the strategy.

Results

The duration from onset to hospitalization in our hospital is statistically shorter, and the mortality and the rate of stage 3 empyema patients are lower in the prospective study group (PSG) than in the retrospective study group (RSG). Retrospective study and prospective study found that surgical group (SG) had more favorable outcomes than non-surgical group (NSG). Although antibiotic treatment duration, hospital stay, and entire mortality were comparable in NSG of both study groups, mortality of patients with PS grade 4 was significantly lower in PSG. SG in PSG had more favorable outcomes than that in RSG, such as antibiotic treatment duration, hospital stay, complication, and mortality.

Conclusions

The good outcomes may be mainly caused by shorter duration from onset to hospitalization and shorter duration from hospitalization to operation. Operative management is an effective procedure for selected patients, and it is important to refer for thoracic surgical consultation earlier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PS:

Performance status

RSG:

Retrospective study group

PSG:

Prospective study group

SG:

Surgical group

NSG:

Non-surgical group

IPR:

Incomplete pulmonary re-expansion

CPR:

Complete pulmonary re-expansion

References

  1. Maskell NA, Batt S, Hedley EL, Davis CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174:817–23.

    Article  Google Scholar 

  2. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3(1):75–80.

    Article  CAS  Google Scholar 

  3. Davies HE, Davies RJ, Davies CW. BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65:41–53.

    Google Scholar 

  4. Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133:346–51.

    Article  Google Scholar 

  5. Nandeesh M, Sharathchandra BJ, Thrishuli PB. ICD versus VATS as primary treatment in fibrinopurulent stage of empyema thoracis. J Clin Diagn Res. 2013;7:2855–8.

    Google Scholar 

  6. Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg. 2006;76:120–2.

    Article  Google Scholar 

  7. Baek JH, Lee YU, Lee SS, Lee JH, Lee JC, Kim MS. Early aggressive surgical treatment of multiloculated empyema. Korean J Thorac Cardiovasc Surg. 2017;50:202–6.

    Article  Google Scholar 

  8. Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011;52:975–81.

    Article  CAS  Google Scholar 

  9. Delaney JA, Schneider-Lindner V, Brassard P, Suissa S. Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med. 2008;6:2. https://doi.org/10.1186/1741-7015-6-2.

    Article  PubMed  Google Scholar 

  10. Sato N, Hoshi E, Aoyama K, Murai K, Ikeya T, Sugita Y, et al. Thoracoscopic treatment of patients with acute bacterial empyema. J Jpn Soc Resp Endosc. 2003;25:279–83.

    Google Scholar 

  11. Rodeheaver GT. Wound cleansing, wound irrigation, wound disinfection. In: Krasner D, Kane D (eds) Chronic wound care: a clinical source book for healthcare professionals. 2nd edn. Health Management Publications, Inc, Wayne; 1997, pp 97–108.

  12. Gossot D, Stern JB, Galetta D, Debrosse D, Girard P, Caliandro R, et al. Thoracoscopic management of postpneumonectomy empyema. Ann Thorac Surg. 2004;78:273–6.

    Article  Google Scholar 

  13. Mennander A, Laurikka J, Kuukasjärvi P, Tarkka M. Continuous pleural lavage may decrease postoperative morbidity in patients undergoing thoracotomy for stage 2 thoracic empyema. Eur J Cardiothorac Surg. 2005;27:32–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hitoshi Suzuki.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suzuki, H., Shomura, S., Sawada, Y. et al. Therapeutic strategy for acute pleural empyema: comparison between retrospective study and prospective study. Gen Thorac Cardiovasc Surg 67, 1048–1055 (2019). https://doi.org/10.1007/s11748-019-01134-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-019-01134-2

Keywords

Navigation